Frostegård E, Bobrova T, Leinebø A, Leray T, Ghosh S, García-Hevia L, Puccinelli C, Riccio L, Sorani J, Bonifazi D, Caumartin J, Donnadieu E, Gazeau F, Hischier R, Inderberg EM, Fanarraga ML, Loustau M, Nowack B, Wälchli S, Ménard-Moyon C(2026) Nanomedicine Meets Immunotherapy: Advancing Adoptive Cell Therapy with Nanoparticles in the Treatment of Cancer with Sustainability Perspectives Adv Sci (Weinh), e22864(in press) DOI 10.1002/advs.202522864, PubMed 41793185
Gjerde CH, Kleinmanns K, Langer A, Ruiz de Garibay Ponce G, Rozmus E, Stangeland GN, Leitch C, Elnour R, Dongre HN, Berger C, Gultekin O, Forcados C, Stensland M, Nyman TA, Lehti K, Davidson B, Wälchli S, Gelebart P, Costea DE, Kotopoulis S, Bjørge L, McCormack E(2026) A 3D ovarian cancer metastasis model using a decellularised peritoneal matrix to study therapy response EBioMedicine, 124, 106135 DOI 10.1016/j.ebiom.2026.106135, PubMed 41633102
Moreno-Sanchez PM, Rezaeipour M, Inderberg EM, Platten M, Golebiewska A(2026) Immunosuppressive mechanisms and therapeutic interventions shaping glioblastoma immunity Nat Cancer, 7(1), 29-42 DOI 10.1038/s43018-025-01097-9, PubMed 41507535
